SEC 13F Intelligence

M28 Capital Management LP / RCKT

M28 Capital Management LP’s Rocket Pharmaceuticals Inc Position

Does M28 Capital Management LP own Rocket Pharmaceuticals Inc (RCKT)? Yes — 210.9K shares worth $754,918 (+1.40% of its 13F portfolio) as of Q1 2026, down from 385.7K shares the prior filed quarter.

Position Value
$754,918
Q1 2026
Shares
210.9K
% of Portfolio
+1.40%
Quarters Held
18
currently held

Position History RCKT

Reported value by quarter
Q4 ’21: $11MQ4 ’21Q1 ’22: $11MQ2 ’22: $10MQ3 ’22: $11MQ3 ’22Q4 ’22: $14MQ1 ’23: $12MQ2 ’23: $13MQ2 ’23Q3 ’23: $11MQ4 ’23: $16MQ1 ’24: $10MQ1 ’24Q2 ’24: $8MQ3 ’24: $7MQ4 ’24: $5MQ4 ’24Q1 ’25: $3MQ2 ’25: $944,916Q3 ’25: $1MQ3 ’25Q4 ’25: $1MQ1 ’26: $754,918filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026210.9K$754,918+1.40%
Q4 2025385.7K$1M+0.98%
Q3 2025385.7K$1M+1.85%
Q2 2025385.7K$944,916+1.61%
Q1 2025385.7K$3M+3.53%
Q4 2024385.7K$5M+4.76%
Q3 2024385.7K$7M+7.83%
Q2 2024385.7K$8M+10.76%
Q1 2024385.7K$10M+7.68%
Q4 2023523.3K$16M+12.99%
Q3 2023523.3K$11M+12.30%
Q2 2023630.4K$13M+16.55%
Q1 2023722.1K$12M+13.99%
Q4 2022722.1K$14M+13.47%
Q3 2022665.9K$11M+11.09%
Q2 2022715.9K$10M+11.04%
Q1 2022715.9K$11M+10.44%
Q4 2021495.3K$11M+8.44%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See M28 Capital Management LP’s full portfolio or all institutional holders of RCKT.